Success Metrics

Clinical Success Rate

90.9%

Based on 10 completed trials

Completion Rate

91%(10/11)

Active Trials

2(11%)

Results Posted

10%(1 trials)

Terminated

1(5%)

Phase Distribution

Ph early_phase_1

Ph phase_4

Ph phase_3

Ph not_applicable

68%

Ph phase_2

16%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution19 total trials

Early Phase 1First-in-human

1(5.3%)

Phase 2Efficacy & side effects

3(15.8%)

Phase 3Large-scale testing

1(5.3%)

Phase 4Post-market surveillance

1(5.3%)

N/ANon-phased studies

13(68.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(10)

Terminated(2)

Other(5)

Detailed Status

Completed10

unknown5

Recruiting2

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (5.3%)

Phase 23 (15.8%)

Phase 31 (5.3%)

Phase 41 (5.3%)

N/A13 (68.4%)

Trials by Status

terminated15%

unknown526%

recruiting211%

withdrawn15%

completed1053%

Recent Activity

2 active trials

Showing 5 of 19

completedphase_2

ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

NCT06429059

recruitingnot_applicable

Clinical Trials (19)

Showing 19 of 19 trials

NCT06429059Phase 2

ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

Completed

NCT07063056Not Applicable

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Recruiting

NCT05138549Phase 2

Astaxanthin for Management of Inflammation in Knee Osteoarthritis

Terminated

NCT05015374Not Applicable

Effect of Astaxanthin on the Patients With Alzheimer Disease

Completed

NCT06460181Phase 4

Impact of Astaxanthin on Cognition in Recreationally Active Females

Recruiting

NCT03310359Not Applicable

Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects

Completed

NCT05409092Not Applicable

Astaxanthin, Exercise Inflammation, Skin Health

Completed

NCT05376501Not Applicable

A Study to Evaluate the Effect of Astaxanthin in Healthy Participants

Completed

NCT03664466Not Applicable

Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators

Withdrawn

NCT05282355Not Applicable

Astaxanthin Reduces Exercising Heart Rate.

Completed

NCT04249128Phase 3

Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)

Completed

NCT04689984Phase 2

The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Unknown

NCT03443882Early Phase 1

Bioavailability of Astaxanthin Formulations

Unknown

NCT03807050Not Applicable

Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin

Completed

NCT02343497Not Applicable

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia

Completed

NCT02373111Not Applicable

Effects of Isoflavone Combined With Astaxanthin on Skin Aging

Completed

NCT02088242Not Applicable

Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in Humans

Unknown

NCT01241877Not Applicable

Astaxanthin Supplementation in Cyclists

Unknown

NCT01167205Not Applicable

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

Unknown

All 19 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 19